In this study, BALB/c mice bearing syngeneic AB12 mesothelioma tumors were intratumorally injected with Ad-expressing IFN-α (Ad.IFN-α), followed by weekly treatments with a combination of cisplatin and gemcitabine. This evidence concerns the gene IFNA1 and mesothelioma.